U.S.-China Relations
NextFin News - Airbus has put divestments on the table, including a potential sale of its US small-satellite business, to clear the path for European Commission approval of a €6.5 billion merger of its space unit with those of Thales and Leonardo. The remedy package, offered as the three groups hold informal talks with Brussels antitrust officials, turns the deal into the first real stress test of the European Union's rewritten merger rules — and of whether the Commission can be seen to rule independently after Commission President Ursula von der Leyen publicly endorsed the transaction.
The deal, and the price of approval
The proposed venture, internally code-named "Project Bromo", would combine the satellite and space activities of three of Europe's largest aerospace groups into a single Toulouse-based company with roughly 25,000 employees and about €6.5 billion in annual revenue. Under a memorandum of understanding signed on 23 October 2025, Airbus would hold 35 percent, with Leonardo and Thales taking 32.5 percent each, in a structure modelled on the MBDA European missile venture. Launchers are excluded. The companies aim for the new entity to be operational in 2027.
The merger has not yet been formally notified to the Commission, and a decision is not expected before the second half of 2027. But remedy discussions are already moving. Airbus is gauging buyer interest in its US space operations, which include a manufacturing facility in Merritt Island, Florida, and the Arrow family of small satellites serving commercial and US government customers. The move is a dual-purpose play: it is a commercial restructuring of a space division that recorded €1.3 billion in charges in 2024, and it is a pre-emptive concession to competition regulators worried the combined group would dominate Europe's institutional satellite market.
The political stakes are unusually high. Speaking at the International Space Summit in Paris, von der Leyen publicly backed the deal and said the Commission had proposed updated merger guidelines "so that they recognize that European companies need scale to invest and compete globally." That intervention is rare for a matter still under competition review — the Commission was reprimanded by the European Ombudsman in 2015 after a former competition chief commented publicly on an ongoing banking-cartel case. DG Comp's director general, Whelan, has since insisted the Commission can "very easily separate" its merger reviews from the president's comments, and that the venture will receive "full rigour" review.
What each party brings — and where the overlaps are
The combination is not a simple roll-up of identical businesses; it is a stacking of complementary but partially overlapping capabilities. Airbus would contribute its Space Systems and Space Digital businesses from the Defence and Space division — the industrial prime behind the OneWeb low-Earth-orbit production line and a major contractor on European institutional programs. Thales and Leonardo would bring their 67/33 and 33/67 joint-venture interests in Thales Alenia Space and Telespazio respectively, plus Thales's Thales SESO optics business. Thales Alenia Space is Europe's largest satellite manufacturer, building everything from telecommunications satellites to the service modules for deep-space exploration; Telespazio is a satellite-services and ground-segment operator running mission control for a wide range of civil and defense programs.
That complementarity is the companies' main antitrust argument: the merged group would be stronger globally because it would offer end-to-end capability, from satellite buses and payloads to launch coordination, ground operations, and downstream data services. But regulators will look harder at the overlaps. All three parents compete for European Space Agency science and exploration contracts, for EU institutional programs such as the Iris² secure-connectivity constellation, and for national defense satellite work. In earth observation, optical payloads and radar imaging, the combined entity would face few European rivals of comparable scale.
The equity-versus-turnover asymmetry sharpens the concern. Airbus's space business accounts for roughly half of the combined venture's turnover but only 35 percent of its equity; Airbus is expected to receive a cash payment from its partners to compensate for that gap. That structure means the three parents retain joint control of a group with outsized access to European public procurement while each parent remains a potential customer and competitor at the system level. Smaller independent makers argue they would be frozen out of the supply chain — and, more importantly, out of the customer relationship with the agencies that fund them.
Why divestments are the price of a European champion
The central regulatory question is not whether Europe wants a space champion — politically, it clearly does. It is whether the champion will compete globally or entrench itself at home. The US asset sale is the cleanest remedy on the table because it removes capacity from the equation rather than merely promising behavioral safeguards. Competition enforcers have long distrusted behavioral remedies in industrial markets: promises to license technology or grant access are hard to monitor and easy to degrade quietly. A buyer for the Florida operation and the Arrow line would leave an independent competitor in place, preserving a rival for US government and commercial small-satellite work.
The sale also fits Airbus's own commercial logic, which is what makes it credible as a remedy rather than a forced carve-out. The group has already shifted production of the next generation of OneWeb broadband satellites back to Toulouse, where Eutelsat has contracted for a further 340 low-Earth-orbit satellites to be built from the end of 2026, on top of a 100-satellite order placed in December 2024. The Florida facility — retooled for the Arrow450 platform only two years ago, after Airbus took full ownership of the Airbus OneWeb Satellites joint venture in January 2024 — has become redundant to that European consolidation. The 105,000-square-foot Merritt Island plant was designed at peak to build up to two spacecraft a day; more than 600 first-generation OneWeb satellites were produced there. With the next batch moving to Toulouse, the site's strategic rationale has narrowed to US government work — the very segment a divestment would hand to a buyer.
The financial context matters. Airbus Defence and Space returned to profitability in 2025, with revenue rising 11 percent to €13.4 billion and adjusted EBIT reaching €798 million, after the €1.3 billion of 2024 charges produced an adjusted EBIT loss of €566 million. In the first half of 2026, division revenue grew 9 percent to €6.32 billion and adjusted EBIT climbed 84 percent to €487 million. Airbus also recorded €105 million in restructuring costs in 2025, with plans to eliminate up to 2,043 positions. The US review is therefore happening inside a wider reshaping of the space business rather than as an immediate response to losses — which is precisely what makes it usable as a remedy. A division that is already cutting cost and consolidating production can present a sale as industrial rationalization, not as a regulatory carve-out that weakens the merged group.
The merger-guidelines test
This deal is the first live case for the Commission's rewritten merger rules, the most significant overhaul of EU merger control in more than two decades. The draft guidelines, published on 30 April 2026 after a public consultation that closed in late June, consolidate the 2004 horizontal and 2008 non-horizontal frameworks into a single document and explicitly recognize that scale-building mergers creating "European champions" can have procompetitive effects and improve EU resilience in global competition. The final text is expected towards the end of 2026 or early 2027 — meaning the Bromo review will be conducted under a framework still in flux.
The political subtext is the Siemens/Alstom rail deal, blocked in 2019 despite strong Franco-German backing. That veto became the rallying point for European industrial-policy advocates who argued the Commission was privileging abstract competition theory over continental strategic autonomy. The new guidelines are designed to make a repeat of that outcome less likely, by giving case teams a structured way to weigh scale efficiencies and global competitive position alongside traditional market-share analysis. But competition chief Teresa Ribera has warned the rules must not become a blank check for corporations to merge at the expense of consumers. The tension between the president's champion-building agenda and the competition directorate's enforcement independence is now embodied in a single file.
There is also a process dimension. Under the EU Merger Regulation, a Phase I review runs 25 working days, extendable to 35 if remedies are offered; a Phase II in-depth investigation runs 90 working days, extendable to 115. Given the novelty of the guidelines, the number of third-party complaints already lodged, and the political sensitivity, a Phase II opening would not be surprising. That timeline sits uneasily against the companies' 2027 operational target.
Cyclical restructuring versus structural consolidation
The divestment and the merger sit on different time horizons, and conflating them produces the wrong verdict. The US asset sale is cyclical: it is a balance-sheet and footprint adjustment inside a division that is mean-reverting back to profitability after the 2024 charges. Revenue is up, margins are recovering, production is consolidating to Toulouse, and the Florida review follows a predictable pattern of post-shock rationalization. If the merger never happened, Airbus would still have been trimming this asset; the divestment will revert to the group's core European footprint and the episode closes.
The merger itself is structural. It is a regime change in the ownership and competitive architecture of the European space industry, not a fluctuation that will self-correct. Once the three parents place their space assets under joint control, the market structure does not snap back: supply chains reconfigure, prime-contractor relationships with ESA and the EU harden around a single counterparty, and independent makers such as OHB lose the option value of remaining outside the champion. A structural shift of this kind will not revert on its own — only a regulator can reverse it, which is why the legal threat matters more than usual. The correct reading is therefore split: a cyclical divestment wrapped inside a structural consolidation, and the antitrust decision applies to the structural layer, not the cyclical one.
The counter-thesis: OHB's legal threat
The strongest opposition comes from within Europe. OHB, one of the continent's few independent satellite makers, has raised fresh capital and positioned itself to contest the deal. CEO Marco Fuchs has called the merger "rather a disturbance of the market" and said in an interview: "We are raising concerns because it impacts our supply chain." When asked whether OHB would consider legal action if the Commission cleared the deal, he said simply: "Yes."
"We are raising concerns because it impacts our supply chain," said OHB chief executive Marco Fuchs, who confirmed the company would consider legal action if the European Commission cleared the Airbus–Thales–Leonardo merger. "It is negative in the sense that it impacts our established value supply chains—and our value creation reality that we have for European Space Agency business."
Fuchs's argument cuts at the foundation of the champions thesis. He dismisses the China comparison that motivates the merger, noting that Europe does not buy satellites from China, and argues the real market is European public procurement — where a consolidated buyer-facing prime would face less competition and taxpayers would pay more. From this angle, the merged group's global ambitions are a cover for rent-seeking at home: the customers that matter are ESA, the European Union, and national ministries, none of which source from Beijing. Spain's Indra Space has also voiced opposition, widening the coalition of complainants beyond Germany.
This is not a fringe complaint; it is the exact theory of harm the Commission must answer if it wants to clear the deal without a court challenge. The Commission's own dilemma is visible in the framing of the question: whether the new company would mainly use its scale to compete globally, as its backers argue, or whether it would reinforce the parents' position in Europe. A clearance that does not convincingly answer that question invites an appeal to the General Court — the kind of litigation that can unravel a remedy package years after closing.
Second-order effects: what the remedy package really signals
The first-order effect of the merger is obvious: a bigger European satellite prime. The second-order effect is what matters. If Brussels approves the deal with divestments, it signals that the updated guidelines genuinely lower the bar for champion-building consolidation in defense-adjacent sectors — inviting a wave of follow-on combinations across European aerospace and defense. Deal teams across the continent are already reading this file; a clearance with manageable remedies would green-light conversations that have been waiting in boardrooms from Munich to Milan.
If the Commission blocks the deal or demands remedies so heavy they unravel the economics, the 2019 Siemens/Alstom precedent stands and the champion agenda stalls. The political cost would fall directly on the von der Leyen Commission, which has made industrial competitiveness central to its mandate and has personally championed this transaction. Either way, the divestment package Airbus offers is the market's first read on how far the Commission will actually go — and the gap between the president's rhetoric and the directorate's enforcement will be measured in assets, not adjectives.
There is also a transatlantic second-order effect. The US small-satellite divestment is not purely a European remedy; it also de-risks the merged group's exposure to US government customers, who are increasingly wary of foreign-controlled suppliers in the space domain. A clean sale to a US or allied buyer preserves access to that market for the assets while letting the European parent group focus on institutional European work. In that sense, the remedy serves two regulators at once.
What to watch
Short term, the deal remains in the informal phase: no formal notification, no timetable beyond "not before H2 2027," and a competition directorate that has publicly committed to a full-rigour review. Market participants should treat the pre-notification period as the real negotiation — this is where remedy scope is set, long before any decision is published. Medium term, the divestment negotiations will define the shape of the new company — a slimmer, Europe-focused group with the US small-satellite business sold off and third-party access conditions written into the clearance. Long term, the outcome will set the template for European industrial consolidation under the new guidelines.
Base case: the Commission clears the venture in 2027 with divestments, including the US space business, plus conditions protecting third-party access to the merged group's technology and supply chains. Upside for the parents: a lighter remedy package that lets the group keep more capacity and move faster toward the 2027 operational target. Downside: a protracted Phase II investigation, a legal challenge from OHB, or a remedy demand heavy enough to push one of the three parents to walk away.
The signal to watch is the formal notification itself — its scope will reveal which assets are being offered and which are being defended. And the falsifying test for the champion thesis is narrow: if, within two years of clearance, the merged group's share of European institutional satellite procurement rises while prices to ESA and EU programs increase, the "global competitor" rationale will have failed and the deal will have been what OHB claims it is.
Brussels is being asked to choose between a champion it can control and a competitor it cannot — and Airbus's divestment offer is the price of the first option.
Explore more exclusive insights at nextfin.ai.
